ASCO Annual Meeting 2022
)
The facility to generate sequencing reads of any length — from short to in excess of 4 Mb — combined with simultaneous base modification identification (e.g. DNA or RNA methylation) and real-time analysis is providing new and actionable insights across the fields of biomedical and cancer research. Discover how researchers are utilising nanopore sequencing for rapid and comprehensive characterisation of SVs, SNVs, fusion transcripts, and splice variants for a range diseases and samples.
Visit us in Innovation Hub IH04 to learn more.
